Publicaciones en colaboración con investigadores/as de French Institute of Health and Medical Research (27)

2023

  1. Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency

    Nature, Vol. 623, Núm. 7988, pp. 803-813

  2. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

    Genome Medicine, Vol. 15, Núm. 1

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  2. HLA-D and PLA2R1 risk alleles associate with recurrent primary membranous nephropathy in kidney transplant recipients

    Kidney International, Vol. 99, Núm. 3, pp. 671-685

2020

  1. Autoantibodies against type I IFNs in patients with life-threatening COVID-19

    Science, Vol. 370, Núm. 6515

  2. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

    Science, Vol. 370, Núm. 6515

2019

  1. EFL1 mutations impair eIF6 release to cause Shwachman-Diamond syndrome

    Blood, Vol. 134, Núm. 3, pp. 277-290

2018

  1. Increased expression of ATP12A proton pump in cystic fibrosis airways

    JCI insight, Vol. 3, Núm. 20

2017

  1. 11β-HSD2 sumoylation modulates cortisol-induced mineralocorticoid receptor nuclear translocation independently of effects on transactivation

    Endocrinology, Vol. 158, Núm. 11, pp. 4047-4063

  2. Aldosterone and Vascular Mineralocorticoid Receptors in Murine Endotoxic and Human Septic Shock

    Critical Care Medicine, Vol. 45, Núm. 9, pp. e954-e962

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

  3. Histone deacetylase 6-controlled Hsp90 acetylation significantly alters mineralocorticoid receptor subcellular dynamics but not its transcriptional activity

    Endocrinology, Vol. 157, Núm. 6, pp. 2515-2532

  4. Tau antagonizes end-binding protein tracking at microtubule ends through a phosphorylation-dependent mechanism

    Molecular Biology of the Cell, Vol. 27, Núm. 19, pp. 2924-2934

2015

  1. Adipocyte mineralocorticoid receptor activation leads to metabolic syndrome and induction of prostaglandin D2 synthase

    Hypertension, Vol. 66, Núm. 1, pp. 149-157

  2. Tau regulates the localization and function of End-binding proteins 1 and 3 in developing neuronal cells

    Journal of Neurochemistry, Vol. 133, Núm. 5, pp. 653-667

2014

  1. Variants of CEP68 gene are associated with acute urticaria/angioedema induced by multiple non-steroidal anti-inflammatory drugs

    PLoS ONE, Vol. 9, Núm. 3

2013

  1. Aldosterone-specific activation of cardiomyocyte mineralocorticoid receptor in vivo

    Hypertension, Vol. 61, Núm. 2, pp. 361-367

  2. The Diuretic Torasemide Does Not Prevent Aldosterone-Mediated Mineralocorticoid Receptor Activation in Cardiomyocytes

    PLoS ONE, Vol. 8, Núm. 9

2012

  1. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010

    The Lancet, Vol. 380, Núm. 9859, pp. 2197-2223